The Relationship Between Cardio-Ankle Vascular Index and Left Atrial Phasic Function in Hypertensive Patients With

Tsuyoshi Tabata1, Kazuhiro Shimizu2, Yukihiro Morinaga1

  • 1Department of Clinical Functional Physiology, Toho University Sakura Medical Center, Chiba, Japan.

Insights

Increased arterial stiffness, measured by cardio-ankle vascular index (CAVI), is linked to impaired left atrial (LA) function in hypertensive patients. This suggests CAVI may help detect early cardiovascular issues.

Area of Science:

  • Cardiovascular Medicine
  • Hypertension Research
  • Vascular Biology

Background:

  • Hypertension is a major risk factor for cardiovascular disease.
  • Arterial stiffness, assessed by cardio-ankle vascular index (CAVI), is an early indicator of vascular damage.
  • Left atrial (LA) dysfunction contributes to cardiovascular events, particularly in hypertensive patients with preserved ejection fraction.

Purpose of the Study:

  • To examine the association between arterial stiffness (CAVI) and LA phasic function.
  • To investigate this relationship in hypertensive patients with preserved left ventricular ejection fraction (LVEF).

Main Methods:

  • Retrospective study of 165 hypertensive patients with preserved LVEF.
  • Simultaneous measurement of CAVI and echocardiography, including speckle-tracking for LA phasic function (reservoir, conduit, pump strain) and LVGLS.
  • Statistical analysis using univariate and multiple linear regression.

Main Results:

  • CAVI correlated significantly with LA reservoir strain (r=-0.387) and LA conduit strain (r=-0.448).
  • Multiple regression revealed CAVI was independently associated with age and LA conduit strain (β=-0.386).
  • No independent association was found between CAVI and LV mass index, LA volume index, or LV systolic function (LVGLS).

Conclusions:

  • Elevated CAVI is independently associated with impaired LA conduit function in hypertensive patients with preserved LVEF.
  • CAVI may serve as an early marker for detecting cardiovascular abnormalities in hypertension.
  • This highlights the potential of CAVI in identifying early interactions between arterial stiffness and atrial function before significant remodeling occurs.

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
72
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
54
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
95
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
135
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
64
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
70